+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer



Synergistic role between p53 and JWA: prognostic and predictive biomarkers in gastric cancer



Plos One 7(12): E52348



Expression of p53 appears to be correlated to prognosis in patients with malignancy, but its role in gastric carcinoma has remained controversial. Recently we reported that JWA, an ADP-ribosylation-like factor 6 interacting protein 5 (ARL6ip5), was both prognostic for overall survival and predictive for platinum-based treatment of gastric cancer. In this study, we aimed to investigate p53 expression as a prognostic and predictive marker in resectable gastric cancer, alone and in combination with JWA. Expression of p53 was examined in three large patient cohorts (total n=1155) of gastric cancer. High expression of p53 was significantly correlated with unfavorable clinicopathologic parameters and decreased overall patient survival. Furthermore, patients with high p53 expression in tumors acquired remarkable survival benefit from adjuvant first-line platinum-based-chemotherapy. The synergy between p53 and JWA in predicting patient outcome was demonstrated, while no significantly elevated predictive value concerning chemotherapy was observed. Thus, p53 expression is a potent prognostic and predictive factor for resectable gastric cancer with adjuvant platinum-based chemotherapy. A combined effect of p53 with JWA as efficient prognostic indicators was found for the first time.

(PDF emailed within 0-6 h: $19.90)

Accession: 056061147

Download citation: RISBibTeXText

PMID: 23285001

DOI: 10.1371/journal.pone.0052348


Related references

Synergistic role of Cul1 and c-Myc: Prognostic and predictive biomarkers in colorectal cancer. Oncology Reports 38(1): 245-252, 2017

Synergistic role of Caspase-8 and Caspase-3 expressions: Prognostic and predictive biomarkers in colorectal cancer. Cancer Biomarkers 21(4): 899-908, 2018

Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?. Virchows Archiv 464(3): 367-378, 2014

Prognostic and putative predictive biomarkers of gastric cancer for personalized medicine. Diagnostic Molecular Pathology 22(3): 127-137, 2014

Prognostic Value of Inflammatory Biomarkers in Gastric Cancer Patients and the Construction of a Predictive Model. Digestive Surgery 2018: 1-10, 2018

How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer. Oncologist 19(10): 1046-1055, 2015

Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Research International 2017: 7869802, 2018

Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. Journal of Translational Medicine 13: 66, 2016

Prognostic and predictive blood biomarkers in gastric cancer and the potential application of circulating tumor cells. World Journal of Gastroenterology 24(21): 2236-2246, 2018

Inflammatory biomarkers in metastatic colorectal cancer: prognostic and predictive role beyond the first line setting. Oncotarget 8(56): 96048-96061, 2017

HDGF and ADAM9 are novel molecular staging biomarkers, prognostic biomarkers and predictive biomarkers for adjuvant chemotherapy in surgically resected stage I non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology 140(8): 1441-1449, 2014

Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management. Breast Cancer Research 17: 21, 2015

Prognostic and predictive role of JWA and XRCC1 expressions in gastric cancer. Clinical Cancer Research 18(10): 2987-2996, 2012

Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World Journal of Gastroenterology 22(35): 7951-7962, 2017

Prognostic and Predictive Biomarkers in Cancer. Current Cancer Drug Targets 14(5): 477-504, 2016